Use of Itraconazole in Treatment or Prevention of Invasive Aspergillosis in Bone Marrow Transplant Recipients.

J.Y.TAM, K.A.HAMED, K.BLUME, and C.G.PROBER.

Abstract: 

The case rate of invasive aspergillosis in bone marrow transplant (BMT) recipients at our institution averaged 9% (33/351) between 1989 and 1991 despite the use of low dose prophylactic amphotericin B (0.15 mg/kg/day) during neutropenia (ANC
1993

abstract No: 

NULL

Full conference title: 

ICAAC 33rd, 1993
    • ICAAC 33rd